Treating Anal Cancer Precursor Lesions Reduces Cancer Risk for People With HIV
A groundbreaking national study led by UCSF finds that treating anal cancer precursor lesions reduces cancer risk for people with HIV.
University of California San Francisco
Displaying 1471 - 1500 of 16507
-
-
Steps in the Development of the Brain’s Cellular Geography Revealed by New Studies
Two new studies of the developing human brain are helping researchers reconcile a long-held debate over how the brain forms.
-
UCSF Leads National Effort to Improve Racial Equity in Kidney Medicine
UCSF leads national efforts to develop new ways of calculating kidney function that leave race out of the equation.
-
Flu Shots and COVID: Do You Need to Worry About Vaccine Timing? What About a ‘Twindemic’?
-
UCSF Celebrates Its Newest Nobel Laureate David Julius
At 2 a.m., a text came that David Julius thought might be a prank. But it was a relative contacting him to say that the Nobel committee in Stockholm was trying to reach him.
-
Treating Severe Depression with On-Demand Brain Stimulation
UCSF Health physicians have successfully treated a patient with severe depression by tapping into the specific brain circuit involved in depressive brain patterns and resetting them using the equivalent of a pacemaker for the brain.
-
Newly Approved Prostate Cancer Scan Can Detect Cells that Have Spread to Lymph Nodes
A new prostate cancer test developed by UCSF and UCLA detects cancer cells that have spread to lymph nodes both inside and outside the pelvis.
-
Nobel Prize Awarded to Scientists for Research About Temperature and Touch
-
2021 Nobel Prize in Physiology or Medicine
-
David Julius Wins Nobel Prize for Work on Pain Sensation
David Julius, PhD, professor and chair of the Department of Physiology and Morris Herzstein Chair in Molecular Biology and Medicine at UC San Francisco, has won the 2021 Nobel Prize in Physiology or Medicine.
-
Biography of David Julius
David Julius, PhD is professor and chair of the Department of Physiology at UC San Francisco and holds the Morris Herzstein Chair in Molecular Biology and Medicine.
-
UCSF and Northwestern Awarded $4.2M to Advance Glioblastoma Therapeutics
Glioblastoma is the most common malignant brain tumor and among the most treatment-resistant cancers. In the last 15 years, numerous attempts to develop new drugs for glioblastoma have failed.
-
UCSF to Survey Entire Community About Climate for Inclusion
UCSF is encouraging every member of its community to participate in a confidential survey designed to help the University better understand people’s perceptions and experiences about the environment in which they work and learn.
-
Looking Beyond DNA to See Cancer with New Clarity
Researchers at UCSF and UC San Diego have mapped out how hundreds of mutations involved in two types of cancer affect the activity of proteins that are the ultimate actors behind the disease.
-
This Molecule Could Be the Key to Understanding Why Concussions Have Such Long-Term Effects
-
UCSF Seismic Safety Review Finds Most Buildings Earthquake Resilient
Committed to the health and safety of its community, the University of California Office of the President (UCOP) voluntarily initiated a review to assess how buildings across the 10-campus system will perform during an earthquake.
-
Exposure to Abuse, Violence Leaves an Immune Signature
Trauma leaves marks on the body, as well as the mind. UCSF scientists have identified an immune signature to indicate which patients will respond best to therapy.
-
Study Links Air Pollution to Nearly 6 Million Preterm Births Around the World
A new analysis looks at how air pollution affects preterm births and other important indicators for newborn babies around the world.
-
Happiness in Early Adulthood May Protect Against Dementia
Research has shown that poor heart health can increase the risk for dementia, but a new study shows that poor mental health in early adulthood may increase odds by 73%.
-
Jennifer Arnett to Lead Fundraising at Mayo Clinic
As UCSF’s top development officer, Jennifer Arnett has led the University through the largest capital campaign in UCSF’s 157-year history.
-
How ‘fits and starts’ of booster science, rollout may affect U.S. vaccination goals
-
New Kidney Function Test Takes Race Out of the Equation
Researchers have identified an approach to remove race from equations used to estimate a person’s kidney function.
-
An Estrogen Receptor that Promotes Cancer also Causes Drug Resistance
Researchers at UCSF have gained insight into how cancer cells proliferate despite a myriad of stresses.
-
Community-Based Strategy Succeeds in Vaccinating Latinx San Franciscans
A community-based effort to overcome vaccine hesitancy designed by UCSF scientists working together with San Francisco’s Latino Task Force is succeeding in the Mission District of San Francisco.
-
Social Scientists File Brief Urging US Supreme Court to Find Mississippi Abortion Ban Unconstitutional
An amicus brief led by experts at UCSF and the University of Texas urges the U.S. Supreme Court to reject Mississippi’s ban on abortions past 15 weeks.
-
New Pediatric ICU Opens to Serve East Bay Children
The 20,000-square-foot facility, located on the second floor of the main hospital building, is the latest milestone in UCSF’s ongoing investment to expand and enhance services in the 109-year-old Oakland hospital for children in Oakland and the greater Bay Area.
-
For These Clinicians, 3D Printers Are Changing Medicine
-
Hospitals Face Urgent Need for Addiction Treatment in Emergency Departments
An increasing percentage of emergency visits and hospitalizations in the United States before the pandemic involved patients with alcohol and other substance use disorders, according to a study by UCSF researchers.
-
Evaluating the New Mu Variant in California
-
The Kidney Project Successfully Tests a Prototype Bioartificial Kidney
The Kidney Project’s implantable bioartificial kidney, one that promises to free kidney disease patients from dialysis machines and transplant waiting lists, took another big step toward becoming reality, earning a $650,000 prize from KidneyX for its first-ever demonstration of a functional prototype of its implantable artificial kidney.
